- Home
- CMBM vs EDSA Comparison
CMBM vs EDSA Comparison
Compare CMBM & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMBM
- EDSA
- Stock Information
- Founded
- CMBM 2011
- EDSA 2015
- Country
- CMBM United States
- EDSA Canada
- Employees
- CMBM N/A
- EDSA N/A
- Industry
- CMBM Radio And Television Broadcasting And Communications Equipment
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- CMBM Technology
- EDSA Health Care
- Exchange
- CMBM Nasdaq
- EDSA Nasdaq
- Market Cap
- CMBM 18.6M
- EDSA 17.2M
- IPO Year
- CMBM 2019
- EDSA N/A
- Fundamental
- Price
- CMBM $0.72
- EDSA $2.40
- Analyst Decision
- CMBM Buy
- EDSA Strong Buy
- Analyst Count
- CMBM 1
- EDSA 2
- Target Price
- CMBM $3.00
- EDSA $13.00
- AVG Volume (30 Days)
- CMBM 173.4K
- EDSA 16.6K
- Earning Date
- CMBM 11-06-2025
- EDSA 08-08-2025
- Dividend Yield
- CMBM N/A
- EDSA N/A
- EPS Growth
- CMBM N/A
- EDSA N/A
- EPS
- CMBM N/A
- EDSA N/A
- Revenue
- CMBM $172,215,000.00
- EDSA N/A
- Revenue This Year
- CMBM N/A
- EDSA N/A
- Revenue Next Year
- CMBM $17.73
- EDSA N/A
- P/E Ratio
- CMBM N/A
- EDSA N/A
- Revenue Growth
- CMBM N/A
- EDSA N/A
- 52 Week Low
- CMBM $0.23
- EDSA $1.55
- 52 Week High
- CMBM $2.08
- EDSA $5.00
- Technical
- Relative Strength Index (RSI)
- CMBM 49.46
- EDSA 53.67
- Support Level
- CMBM $0.62
- EDSA $2.41
- Resistance Level
- CMBM $0.77
- EDSA $2.48
- Average True Range (ATR)
- CMBM 0.06
- EDSA 0.09
- MACD
- CMBM 0.00
- EDSA -0.01
- Stochastic Oscillator
- CMBM 44.10
- EDSA 51.85
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.